Literature
Prescott Group staff members' contributions to the medical literature include the following publications:
Depression
A phase 3, double-blind, randomized, placebo-controlled study of vilazodone in adolescents with major depressive disorder.
Durgam S, Chen C, Migliore R, et al. Paediatr Drugs. 2018;20(4):353-363.
Dermatology
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT).
Lebwohl M, Blauvelt A, Paul C, et al. J Am Acad Dermatol. 2018;79(2):266-276.e5.
HIV
Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-PI.
Arribas JR, DeJesus E, van Lunzen J, et al. HIV Clin Trials. 2017;18(3):118-125.
Epilepsy
Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study.
Gidal BE, Wechsler RT, Sankar R, et al. Neurology. 2016;87(17):1806-1812.
Hypertension
Rationale for nebivolol/valsartan combination for hypertension: Review of preclinical and clinical data.
Giles TD, Cockcroft JR, Pitt B, Jakate A, Wright HM. J Hypertens. 2017;35(9):1758-67.
Migraine
AVP-825: A novel intranasal delivery system for low-dose sumatriptanpowder in the treatment of acute migraine.
Silberstein S. Expert Rev Clin Pharmacol. 2017;10(8):821-32.
Respiratory
Effect of roflumilast and inhaled corticosteroid/long-acting beta2-agonist on chronic obstructive pulmonary disease exacerbations (RE2SPOND). A randomized clinical trial.
Martinez FJ, Rabe KF, Sethi S, et al. Am J Respir Crit Care Med. 2016;194(5):559-67.
Schizophrenia
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: A randomised, double-blind, controlled trial.
Németh G, Laszlovszky I, Czobor P, et al. Lancet. 2017;389(10074):1103-1113.
Tardive Dyskinesia
KINECT 3: A phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia.
Hauser RA, Factor SA, Marder SR, et al. Am J Psychiatry. 2017;174(5):476-484.
Urology
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
Kleinmann N, Matin SF, Pierorazio PM, et al. Lancet Oncol. 2020;21(6):776-785.
Women's Health
Ulipristal acetate for treatment of symptomatic uterine leiomyomas: A randomized controlled trial.
Simon JA, Catherino W, Segars JH, et al. Obstet Gynecol. 2018;131(3):431-439.